 Beth Tamburini
Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B7-H1 Antigen | 7 | 2025 | 224 | 3.360 |
Why?
| | Lymph Nodes | 8 | 2025 | 500 | 3.030 |
Why?
| | Endothelial Cells | 11 | 2025 | 813 | 2.960 |
Why?
| | Antigens | 5 | 2025 | 361 | 2.950 |
Why?
| | Dendritic Cells | 9 | 2025 | 502 | 2.600 |
Why?
| | Lymphatic Vessels | 7 | 2020 | 63 | 1.780 |
Why?
| | Cell Movement | 4 | 2025 | 982 | 1.240 |
Why?
| | Antigen Presentation | 4 | 2021 | 219 | 1.220 |
Why?
| | Programmed Cell Death 1 Receptor | 2 | 2021 | 260 | 1.120 |
Why?
| | Endothelium, Lymphatic | 2 | 2018 | 11 | 1.050 |
Why?
| | CD8-Positive T-Lymphocytes | 6 | 2024 | 915 | 0.950 |
Why?
| | Single-Cell Analysis | 5 | 2025 | 337 | 0.930 |
Why?
| | B7-1 Antigen | 1 | 2025 | 57 | 0.900 |
Why?
| | Liver | 5 | 2024 | 1815 | 0.810 |
Why?
| | Paxillin | 1 | 2022 | 11 | 0.780 |
Why?
| | Mice, Inbred C57BL | 16 | 2025 | 5895 | 0.770 |
Why?
| | Saccharomyces cerevisiae | 5 | 2012 | 556 | 0.700 |
Why?
| | Dermis | 1 | 2020 | 33 | 0.670 |
Why?
| | Hemangiosarcoma | 2 | 2010 | 23 | 0.630 |
Why?
| | Immunity | 1 | 2020 | 139 | 0.630 |
Why?
| | Interferon Type I | 2 | 2018 | 141 | 0.620 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2020 | 263 | 0.610 |
Why?
| | Signal Transduction | 2 | 2025 | 5148 | 0.610 |
Why?
| | Mice | 19 | 2025 | 18057 | 0.590 |
Why?
| | Vaccines | 2 | 2022 | 405 | 0.580 |
Why?
| | Animals | 26 | 2025 | 37579 | 0.550 |
Why?
| | Saccharomyces cerevisiae Proteins | 4 | 2008 | 403 | 0.550 |
Why?
| | Immunity, Cellular | 2 | 2019 | 267 | 0.540 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1241 | 0.540 |
Why?
| | Histones | 4 | 2008 | 638 | 0.530 |
Why?
| | Hepatitis C, Chronic | 1 | 2019 | 146 | 0.530 |
Why?
| | Gene Expression Profiling | 3 | 2025 | 1761 | 0.530 |
Why?
| | Cell Proliferation | 4 | 2019 | 2497 | 0.500 |
Why?
| | Flow Cytometry | 1 | 2019 | 1195 | 0.440 |
Why?
| | Molecular Chaperones | 3 | 2008 | 198 | 0.430 |
Why?
| | T-Lymphocytes | 4 | 2015 | 2003 | 0.430 |
Why?
| | Cell Differentiation | 3 | 2019 | 1999 | 0.420 |
Why?
| | Antigens, Viral | 1 | 2014 | 178 | 0.410 |
Why?
| | Viral Vaccines | 1 | 2014 | 107 | 0.390 |
Why?
| | Immunotherapy | 2 | 2021 | 643 | 0.380 |
Why?
| | Cell Cycle Proteins | 3 | 2008 | 632 | 0.370 |
Why?
| | Virus Diseases | 1 | 2014 | 215 | 0.360 |
Why?
| | Dogs | 2 | 2010 | 426 | 0.350 |
Why?
| | Lymphocyte Activation | 5 | 2021 | 1141 | 0.330 |
Why?
| | Breast Neoplasms | 2 | 2019 | 2235 | 0.320 |
Why?
| | Poly I-C | 2 | 2020 | 63 | 0.310 |
Why?
| | Lipoproteins, LDL | 2 | 2020 | 112 | 0.310 |
Why?
| | Silent Information Regulator Proteins, Saccharomyces cerevisiae | 2 | 2006 | 8 | 0.310 |
Why?
| | Breeding | 1 | 2009 | 65 | 0.300 |
Why?
| | Neovascularization, Pathologic | 1 | 2010 | 295 | 0.300 |
Why?
| | Mice, Knockout | 6 | 2021 | 3064 | 0.290 |
Why?
| | Dog Diseases | 1 | 2009 | 65 | 0.290 |
Why?
| | Gene Silencing | 2 | 2006 | 197 | 0.270 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 447 | 0.270 |
Why?
| | Interleukin-6 | 1 | 2012 | 777 | 0.270 |
Why?
| | Biomarkers | 1 | 2019 | 4175 | 0.270 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2010 | 1430 | 0.260 |
Why?
| | DNA Repair | 2 | 2008 | 239 | 0.260 |
Why?
| | Transcriptome | 2 | 2025 | 1007 | 0.260 |
Why?
| | Melanoma, Experimental | 2 | 2025 | 111 | 0.250 |
Why?
| | DNA | 2 | 2021 | 1438 | 0.250 |
Why?
| | Ribonucleases | 1 | 2006 | 48 | 0.240 |
Why?
| | Mice, Transgenic | 4 | 2021 | 2176 | 0.240 |
Why?
| | Antigens, CD | 2 | 2019 | 544 | 0.240 |
Why?
| | Mutation | 4 | 2022 | 3999 | 0.230 |
Why?
| | Lymphoid Tissue | 2 | 2022 | 80 | 0.220 |
Why?
| | Recombination, Genetic | 1 | 2005 | 206 | 0.210 |
Why?
| | Psoriasis | 1 | 2025 | 110 | 0.210 |
Why?
| | Chemokine CCL21 | 2 | 2020 | 13 | 0.210 |
Why?
| | Cell Line, Tumor | 4 | 2021 | 3487 | 0.200 |
Why?
| | Ovalbumin | 2 | 2021 | 196 | 0.200 |
Why?
| | Mice, Inbred BALB C | 3 | 2021 | 1271 | 0.190 |
Why?
| | Receptors, Pattern Recognition | 1 | 2022 | 14 | 0.190 |
Why?
| | Repressor Proteins | 3 | 2021 | 428 | 0.190 |
Why?
| | Vaccinia virus | 1 | 2022 | 42 | 0.190 |
Why?
| | Humans | 17 | 2025 | 140898 | 0.190 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 2 | 2019 | 66 | 0.180 |
Why?
| | Liver Cirrhosis | 1 | 2024 | 283 | 0.180 |
Why?
| | Protein Binding | 2 | 2025 | 2238 | 0.180 |
Why?
| | Macrophages | 2 | 2021 | 1559 | 0.180 |
Why?
| | Fatty Liver | 1 | 2024 | 232 | 0.180 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 2 | 2021 | 43 | 0.180 |
Why?
| | Phosphorothioate Oligonucleotides | 1 | 2021 | 9 | 0.180 |
Why?
| | Caveolae | 1 | 2021 | 17 | 0.170 |
Why?
| | Chikungunya Fever | 2 | 2021 | 80 | 0.170 |
Why?
| | Alphavirus Infections | 1 | 2021 | 45 | 0.170 |
Why?
| | Disease Models, Animal | 4 | 2025 | 4407 | 0.170 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 26 | 0.170 |
Why?
| | Inflammation | 3 | 2019 | 2891 | 0.170 |
Why?
| | Tumor Microenvironment | 3 | 2021 | 699 | 0.170 |
Why?
| | STAT3 Transcription Factor | 1 | 2022 | 211 | 0.170 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 32 | 0.170 |
Why?
| | Receptors, CCR7 | 1 | 2020 | 31 | 0.170 |
Why?
| | Immune System | 1 | 2022 | 183 | 0.170 |
Why?
| | Receptors, CCR2 | 1 | 2020 | 39 | 0.170 |
Why?
| | Azetidines | 1 | 2020 | 46 | 0.170 |
Why?
| | Viremia | 1 | 2021 | 149 | 0.170 |
Why?
| | Tissue Distribution | 1 | 2021 | 327 | 0.160 |
Why?
| | Radiation Tolerance | 1 | 2021 | 104 | 0.160 |
Why?
| | Receptors, Immunologic | 1 | 2021 | 215 | 0.160 |
Why?
| | Endocytosis | 1 | 2021 | 173 | 0.160 |
Why?
| | Chemotaxis | 1 | 2020 | 134 | 0.160 |
Why?
| | GTP-Binding Proteins | 1 | 2020 | 151 | 0.160 |
Why?
| | Polymerization | 1 | 2020 | 126 | 0.160 |
Why?
| | Cell Count | 1 | 2020 | 325 | 0.160 |
Why?
| | Protein Kinase Inhibitors | 2 | 2020 | 917 | 0.160 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 174 | 0.160 |
Why?
| | Membrane Glycoproteins | 2 | 2019 | 501 | 0.150 |
Why?
| | Cells, Cultured | 2 | 2021 | 4199 | 0.150 |
Why?
| | Postpartum Period | 2 | 2019 | 343 | 0.150 |
Why?
| | Exons | 1 | 2020 | 352 | 0.150 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 2019 | 68 | 0.150 |
Why?
| | Platelet Factor 4 | 1 | 2019 | 35 | 0.150 |
Why?
| | Receptors, Interferon | 1 | 2019 | 52 | 0.150 |
Why?
| | Protein Domains | 1 | 2020 | 303 | 0.150 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2021 | 193 | 0.150 |
Why?
| | Female | 10 | 2025 | 75540 | 0.140 |
Why?
| | Actins | 1 | 2020 | 423 | 0.140 |
Why?
| | Mammary Glands, Human | 1 | 2018 | 66 | 0.140 |
Why?
| | Semaphorins | 1 | 2018 | 35 | 0.140 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2021 | 393 | 0.140 |
Why?
| | Mice, 129 Strain | 1 | 2017 | 86 | 0.140 |
Why?
| | Hypersensitivity | 1 | 2020 | 260 | 0.130 |
Why?
| | Chikungunya virus | 1 | 2018 | 82 | 0.130 |
Why?
| | Peptide Fragments | 1 | 2021 | 698 | 0.130 |
Why?
| | Cell Division | 1 | 2019 | 792 | 0.130 |
Why?
| | Adaptive Immunity | 1 | 2018 | 172 | 0.130 |
Why?
| | Cell Communication | 1 | 2019 | 316 | 0.130 |
Why?
| | Base Sequence | 1 | 2020 | 2169 | 0.130 |
Why?
| | Amino Acids | 1 | 2020 | 493 | 0.130 |
Why?
| | Sulfonamides | 1 | 2020 | 565 | 0.130 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2020 | 1112 | 0.120 |
Why?
| | Phosphorylation | 1 | 2020 | 1758 | 0.120 |
Why?
| | Head and Neck Neoplasms | 1 | 2021 | 553 | 0.120 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2021 | 832 | 0.120 |
Why?
| | CD27 Ligand | 1 | 2015 | 9 | 0.120 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2015 | 28 | 0.120 |
Why?
| | Cell Survival | 1 | 2018 | 1129 | 0.110 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2014 | 85 | 0.110 |
Why?
| | Down Syndrome | 1 | 2020 | 505 | 0.100 |
Why?
| | RNA, Messenger | 1 | 2021 | 2822 | 0.100 |
Why?
| | Chronic Disease | 1 | 2019 | 1811 | 0.100 |
Why?
| | DNA Damage | 2 | 2005 | 429 | 0.090 |
Why?
| | Epithelial Cells | 1 | 2018 | 1113 | 0.090 |
Why?
| | Male | 7 | 2024 | 69893 | 0.090 |
Why?
| | Immunologic Memory | 1 | 2013 | 359 | 0.090 |
Why?
| | Interleukin-12 | 1 | 2012 | 123 | 0.090 |
Why?
| | CD40 Antigens | 1 | 2012 | 89 | 0.090 |
Why?
| | Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2010 | 15 | 0.090 |
Why?
| | Th17 Cells | 1 | 2012 | 107 | 0.080 |
Why?
| | Lipoproteins | 1 | 2012 | 163 | 0.080 |
Why?
| | Cysteine | 1 | 2012 | 208 | 0.080 |
Why?
| | Time Factors | 1 | 2021 | 6944 | 0.080 |
Why?
| | ras Proteins | 1 | 2010 | 145 | 0.080 |
Why?
| | Apoptosis | 1 | 2019 | 2571 | 0.080 |
Why?
| | Inheritance Patterns | 1 | 2009 | 44 | 0.080 |
Why?
| | Antineoplastic Agents | 1 | 2020 | 2156 | 0.080 |
Why?
| | Transcription, Genetic | 2 | 2006 | 1485 | 0.070 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2009 | 72 | 0.070 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 757 | 0.070 |
Why?
| | Histone Acetyltransferases | 2 | 2008 | 63 | 0.070 |
Why?
| | DNA, Fungal | 1 | 2008 | 80 | 0.070 |
Why?
| | Combined Modality Therapy | 2 | 2021 | 1240 | 0.070 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2008 | 103 | 0.070 |
Why?
| | Lysine | 2 | 2008 | 292 | 0.060 |
Why?
| | Gene Regulatory Networks | 1 | 2009 | 310 | 0.060 |
Why?
| | Aged, 80 and over | 1 | 2019 | 7899 | 0.060 |
Why?
| | Genes, Fungal | 1 | 2006 | 51 | 0.060 |
Why?
| | Genes, Dominant | 1 | 2006 | 97 | 0.060 |
Why?
| | Acid Phosphatase | 1 | 2005 | 20 | 0.060 |
Why?
| | Genetic Complementation Test | 1 | 2005 | 66 | 0.060 |
Why?
| | Checkpoint Kinase 2 | 1 | 2005 | 29 | 0.060 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 2005 | 14 | 0.060 |
Why?
| | Acetyltransferases | 1 | 2005 | 21 | 0.060 |
Why?
| | Neoplasms | 1 | 2020 | 2718 | 0.060 |
Why?
| | Immunoprecipitation | 1 | 2005 | 153 | 0.060 |
Why?
| | Sirtuin 2 | 1 | 2005 | 24 | 0.060 |
Why?
| | Sirtuins | 1 | 2005 | 39 | 0.060 |
Why?
| | Conserved Sequence | 1 | 2005 | 238 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2005 | 391 | 0.060 |
Why?
| | Acetylation | 1 | 2005 | 245 | 0.050 |
Why?
| | Bleomycin | 1 | 2005 | 248 | 0.050 |
Why?
| | Green Fluorescent Proteins | 1 | 2005 | 401 | 0.050 |
Why?
| | DNA Replication | 1 | 2005 | 239 | 0.050 |
Why?
| | Histone Deacetylases | 1 | 2005 | 207 | 0.050 |
Why?
| | Drosophila Proteins | 1 | 2005 | 206 | 0.050 |
Why?
| | Drosophila melanogaster | 1 | 2005 | 237 | 0.050 |
Why?
| | Protein Kinases | 1 | 2005 | 308 | 0.050 |
Why?
| | Binding Sites | 1 | 2006 | 1315 | 0.050 |
Why?
| | Vaccination | 1 | 2012 | 1467 | 0.050 |
Why?
| | Alphavirus | 1 | 2021 | 22 | 0.040 |
Why?
| | Kupffer Cells | 1 | 2021 | 49 | 0.040 |
Why?
| | Amino Acid Sequence | 1 | 2005 | 2152 | 0.040 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2021 | 27 | 0.040 |
Why?
| | Mice, Mutant Strains | 1 | 2021 | 306 | 0.040 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2021 | 80 | 0.040 |
Why?
| | Molecular Sequence Data | 1 | 2005 | 2917 | 0.040 |
Why?
| | Lymphocyte Depletion | 1 | 2021 | 136 | 0.040 |
Why?
| | Intercellular Junctions | 1 | 2020 | 38 | 0.040 |
Why?
| | Proteostasis | 1 | 2020 | 27 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 1 | 2009 | 2368 | 0.040 |
Why?
| | Permeability | 1 | 2020 | 165 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2024 | 719 | 0.040 |
Why?
| | Tumor Burden | 1 | 2021 | 310 | 0.040 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 189 | 0.040 |
Why?
| | Purines | 1 | 2020 | 182 | 0.040 |
Why?
| | Interferon-alpha | 1 | 2020 | 196 | 0.040 |
Why?
| | Aged | 1 | 2019 | 24666 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2020 | 250 | 0.040 |
Why?
| | Venules | 1 | 2018 | 15 | 0.040 |
Why?
| | Lymphangiogenesis | 1 | 2018 | 27 | 0.040 |
Why?
| | Crosses, Genetic | 1 | 2018 | 133 | 0.040 |
Why?
| | GPI-Linked Proteins | 1 | 2018 | 78 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 370 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 1 | 2020 | 325 | 0.030 |
Why?
| | Integrins | 1 | 2018 | 95 | 0.030 |
Why?
| | Stromal Cells | 1 | 2018 | 116 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2005 | 1478 | 0.030 |
Why?
| | Mammary Glands, Animal | 1 | 2018 | 131 | 0.030 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2020 | 255 | 0.030 |
Why?
| | RNA, Viral | 1 | 2021 | 691 | 0.030 |
Why?
| | Middle Aged | 1 | 2019 | 34487 | 0.030 |
Why?
| | Transcription Factors | 1 | 2005 | 1703 | 0.030 |
Why?
| | Pyrazoles | 1 | 2020 | 480 | 0.030 |
Why?
| | Homeodomain Proteins | 1 | 2020 | 512 | 0.030 |
Why?
| | Epitopes | 1 | 2018 | 477 | 0.030 |
Why?
| | Immunization | 1 | 2018 | 405 | 0.030 |
Why?
| | Adult | 1 | 2019 | 39134 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 674 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2015 | 244 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 852 | 0.030 |
Why?
| | B-Lymphocytes | 1 | 2018 | 857 | 0.020 |
Why?
| | Phenotype | 1 | 2021 | 3172 | 0.020 |
Why?
| | Vaccines, Subunit | 1 | 2012 | 50 | 0.020 |
Why?
| | Immunity, Humoral | 1 | 2012 | 116 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2008 | 136 | 0.020 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2008 | 47 | 0.020 |
Why?
| | Phosphoproteins | 1 | 2008 | 335 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2008 | 438 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1822 | 0.010 |
Why?
|
|
Tamburini's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|